Search results
Showing 16 to 30 of 127 results for thyroid* OR hypothyroid* OR Hyperthyroid* OR goiter
Evidence-based recommendations on selpercatinib (Retsevmo) for advanced thyroid cancer with RET alterations after treatment with a targeted cancer drug in people 12 years and over.
Evidence-based recommendations on selpercatinib (Retsevmo) for advanced thyroid cancer with RET alterations untreated with a targeted cancer drug in people 12 years and over.
Selpercatinib for untreated RET-positive advanced thyroid cancer [ID6183]
In development Reference number: GID-TA11160 Expected publication date: TBC
In development Reference number: GID-TA11531 Expected publication date: TBC
This indicator covers the contractor establishing and maintaining a register of patients with hypothyroidism who are currently treated with levothyroxine. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM99.
Diabetes: thyroid disease screening (children T1DM) (IND312)
This indicator covers the proportion of children and young people aged under 18 years with type 1 diabetes who have been screened for thyroid disease in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes
This indicator covers the percentage of patients on the learning disability register with Down's Syndrome aged 18 and over who have a record of blood TSH in the previous 15 months (excluding those who are on the thyroid disease register). It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM04
This indicator covers the percentage of patients with dementia (diagnosed on or after 1 April 2014) with a record of FBC, calcium, glucose, renal and liver function, thyroid function tests, serum vitamin B12 and folate levels recorded up to 12 months before entering on to the register. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM72
effectiveness of dosimetry-guided radioactive iodine strategies for hyperthyroidism? Any explanatory notes(if applicable) Why the...
What is the clinical and cost effectiveness of selenium for people with subclinical hypothyroidism?
subclinical hypothyroidism? Any explanatory notes(if applicable) Source guidance details Comes from guidance Thyroid...
What is the clinical and cost effectiveness of iodine for people with subclinical hypothyroidism?
subclinical hypothyroidism? Any explanatory notes(if applicable) Source guidance details Comes from guidance Thyroid...
subclinical hypothyroidism? Any explanatory notes(if applicable) Source guidance details Comes from guidance Thyroid...
liothyronine (T3) combination therapy compared with T4 alone for people with hypothyroidism whose symptoms have not responded...
and cost effectiveness, including safety, of radioactive iodine for hyperthyroidism? Any explanatory notes(if applicable) Why the...
for improving long-term health outcomes for people with subclinical hyperthyroidism? Any explanatory notes(if applicable) Why the...